Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J. Bandres E, et al. Among authors: ramirez n. Clin Cancer Res. 2009 Apr 1;15(7):2281-90. doi: 10.1158/1078-0432.CCR-08-1818. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318487 Free article.
Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, Garcia-Foncillas J. Bandres E, et al. Among authors: ramirez n. Int J Cancer. 2009 Dec 1;125(11):2737-43. doi: 10.1002/ijc.24638. Int J Cancer. 2009. PMID: 19521961 Free article.
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.
Zarate R, Rodríguez J, Bandres E, Patiño-Garcia A, Ponz-Sarvise M, Viudez A, Ramirez N, Bitarte N, Chopitea A, Gacía-Foncillas J. Zarate R, et al. Among authors: ramirez n. Br J Cancer. 2010 Mar 16;102(6):987-94. doi: 10.1038/sj.bjc.6605595. Epub 2010 Mar 9. Br J Cancer. 2010. PMID: 20216541 Free PMC article. Clinical Trial.
The abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by multimer technology in Adoptive Immunotherapy.
Beloki L, Ciáurriz M, Mansilla C, Bandrés E, Rodríguez-Calvillo M, Ramírez N, Olavarría E. Beloki L, et al. Among authors: ramirez n. J Immunol Methods. 2013 Oct 31;396(1-2):168-72. doi: 10.1016/j.jim.2013.07.014. Epub 2013 Aug 6. J Immunol Methods. 2013. PMID: 23933324
559 results